Does the Final Intraoperative PTH Level Really Have to Fall into the Normal Range to Signify Cure?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Intraoperative parathyroid hormone (IOPTH) helps shorten the duration of surgery and increase the likelihood of surgical cure. Although general consensus agrees that the IOPTH should fall by 50%, there is much debate as to whether the IOPTH needs to fall into the normal range.
We retrospectively reviewed a prospective database of patients undergoing surgery for treatment of primary hyperparathyroidism. We included all patients with an IOPTH that fell by >50% by 10 or 15 min, but that did not fall into the normal range (parathyroid hormone remained ≥60 pg/ml). We excluded patients who had undergone prior neck surgery or had known multiple endocrine neoplasia 1 or 2.
A total of 1,231 patients underwent a parathyroidectomy, 155 of whom met the study’s inclusion/exclusion criteria (12.6%). A total of 117 patients had an IOPTH fall by 50% by 10 min, and 38 patients’ IOPTH fell by 50% by 15 min. Overall surgical cure rate was 98.7%. One patient from the 10-minute group and one patient from the 15-minute group had persistent disease on follow-up. One patient in the 15-minute group had recurrent disease. With a mean ± SEM 18.1 ± 2.1 months’ follow-up, the recurrence rate in this cohort was 0.6%. The average calcium at last follow-up was 9.4 ± 0.0 mg/dl.
Allowing the IOPTH to fall by 50% by 15 min, regardless of whether the IOPTH falls into the normal range, results in a high success rate when performed by experienced surgeons. This helps reduce intraoperative time used waiting for additional parathyroid hormone levels and the risks associated with unnecessary bilateral neck exploration.
- Fraker, DL, Harsono, H, Lewis, R (2009) Minimally invasive parathyroidectomy: benefits and requirements of localization, diagnosis, and intraoperative PTH monitoring. Long-term results. World J Surg 33: pp. 2256-2265 CrossRef
- Chen, H, Sokoll, LJ, Udelsman, R (1999) Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay. Surgery 126: pp. 1016-1021 CrossRef
- Irvin, GL, Carneiro, DM, Solorzano, CC (2004) Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg 239: pp. 704-708 CrossRef
- Sugg, SL, Krzywda, EA, Demeure, MJ, Wilson, SD (2004) Detection of multiple gland primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Surgery 136: pp. 1303-1309 CrossRef
- Carneiro, DM, Solorzano, CC, Nader, MC, Ramirez, M, Irvin, GL (2003) Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate?. Surgery 134: pp. 973-979 CrossRef
- Nussbaum, SR, Thompson, AR, Hutcheson, KA, Gaz, RD, Wang, CA (1988) Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery 104: pp. 1121-1127
- Ypsilantis, E, Charfare, H, Wassif, WS (2010) Intraoperative PTH assay during minimally invasive parathyroidectomy may be helpful in the detection of double adenomas and may minimise the risk of recurrent surgery. Int J Endocrinol 2010: pp. 178671
- Irvin, GL, Dembrow, VD, Prudhomme, DL (1991) Operative monitoring of parathyroid gland hyperfunction. Am J Surg 162: pp. 299-302 CrossRef
- Karakousis, GC, Han, D, Kelz, RR (2007) Interpretation of intra-operative PTH changes in patients with multi-glandular primary hyperparathyroidism (pHPT). Surgery 142: pp. 845-850 CrossRef
- Jaskowiak, NT, Sugg, SL, Helke, J, Koka, MR, Kaplan, EL (2002) Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. Arch Surg 137: pp. 659-668 CrossRef
- Chiu, B, Sturgeon, C, Angelos, P (2006) Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients. Arch Surg 141: pp. 483-487 CrossRef
- Cook, MR, Pitt, SC, Schaefer, S, Sippel, R, Chen, H (2010) A rising ioPTH level immediately after parathyroid resection: are additional hyperfunctioning glands always present? An application of the Wisconsin criteria. Ann Surg 251: pp. 1127-1130 CrossRef
- Chen, H, Pruhs, Z, Starling, JR, Mack, E (2005) Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 138: pp. 583-587 CrossRef
- Libutti, SK, Alexander, HR, Bartlett, DL (1999) Kinetic analysis of the rapid intraoperative parathyroid hormone assay in patients during operation for hyperparathyroidism. Surgery 126: pp. 1145-1150 CrossRef
- Westerdahl, J, Bergenfelz, A (2007) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg 246: pp. 976-980 CrossRef
- Westerdahl, J, Lindblom, P, Bergenfelz, A (2002) Measurement of intraoperative parathyroid hormone predicts long-term operative success. Arch Surg 137: pp. 186-190 CrossRef
- Hermsen, D, Franzson, L, Hoffmann, JP (2002) Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010. Clin Lab 48: pp. 131-141
- Carneiro-Pla, DM, Solorzano, CC, Lew, JI, Irvin, GL (2008) Long-term outcome of patients with intraoperative parathyroid level remaining above the normal range during parathyroidectomy. Surgery 144: pp. 989-993 CrossRef
- Cayo, AK, Sippel, RS, Schaefer, S, Chen, H (2009) Utility of intraoperative PTH for primary hyperparathyroidism due to multigland disease. Ann Surg Oncol 16: pp. 3450-3454 CrossRef
- Beyer, TD, Solorzano, CC, Starr, F, Nilubol, N, Prinz, RA (2007) Parathyroidectomy outcomes according to operative approach. Am J Surg 193: pp. 368-372 CrossRef
- Does the Final Intraoperative PTH Level Really Have to Fall into the Normal Range to Signify Cure?
Annals of Surgical Oncology
Volume 19, Issue 6 , pp 1862-1867
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Division of Endocrinology, Department of Internal Medicine, University of Wisconsin, Madison, WI, USA
- 2. Department of Surgery, Section of Endocrine Surgery, University of Wisconsin, Madison, WI, USA